Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors
/in Dendritic Cells, International Publications /von 2009-11-04 / Vaccine 2009 Dec;28(2):542-7Heat-shock protein vaccines as active immunotherapy against human gliomas
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications /von 2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-82Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia
/in Hyperthermia, International Publications /von 2009-11-01 / Radiother Oncol 2009 Nov;93(2):358-63Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate
/in Hypernephroma, International Publications /von 2009-11-01 / Scand. J. Immunol. 2009 Nov;70(5):481-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution